EUVIMEDEUVIMED entdecken
Crossref

Pharmacokinetics and oral bioavailability of cannabidiol in horses after intravenous and oral administration with oil and micellar formulations

Antonia Sánchez de Medina, Juan Manuel Serrano-Rodríguez iD, Elisa Díez de Castro iD, María Teresa García-Valverde, Aritz Saitua, Mireia Becero, Ana Muñoz iD, Carlos Ferreiro-Vera, Verónica Sánchez de Medina iD

Equine Veterinary Journal · 2023

DOI: 10.1111/evj.13923 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Equine Veterinary Journal, 2023. Verfasst von Antonia Sánchez de Medina und 8 weiteren Autor:innen. Beteiligte Einrichtung: Veterinary Clinical Hospital, University of Cordoba, Córdoba, Spain. Hauptthemen laut MEDLINE: Cannabidiol. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Phytoplant Research S.L.U., Institut Hospital del Mar d'Investigacions Mèdiques, Hospital Del Mar Medical Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Intravenous pharmacokinetics and oral bioavailability of cannabidiol (CBD) with different formulations have not been investigated in horses and may represent a starting point for clinical studies.

Objectives

To describe pharmacokinetics after intravenous and oral administrations with oil and micellar formulations and simulate different treatments. Study design Single intravenous experiment and two‐way randomised oral experiments, Latin‐square design.

Methods

Eight healthy horses received intravenous CBD at 1.00 mg/kg dose, oral CBD in sesame oil and in micellar formulation, both at 10.00 mg/kg. Concentrations were measured using LC–MS/MS and fitted by nonlinear mixed effect modelling. Parameters obtained were used to simulate single and multiple treatments at steady state.

Results

Intravenous and oral concentrations were simultaneously fitted using a three‐compartment model. Final estimates indicate that CBD has a volume of distribution of 36 L/kg associated with a systemic clearance of 1.46 L/h/kg and half‐lives ranged between 24 and 34 h. Oral bioavailability was close to 14% for both oral administrations. Simulated dose regimen of CBD every 12 and 24 h predicted similar percentages to reach effective plasma concentration with both oral formulation at 10.00 mg/kg. Main limitations A small horse population was used (8 horses per trial). Conclusions and clinical importance Oral bioavailability was low at the doses studied but fell within the range described for horse and other species. CBD had a high steady‐state volume of distribution, a high clearance and long half‐lives. No adverse reactions were detected at any dose or route. The micellar formulation showed a faster absorption and higher concentration peak, while the oil formulation presented lower levels, but more maintained over time. Simulations predicted that both could be useful in multiple oral dose treatments. These results indicated that CBD could be of interest, but further studies are needed to evaluate its clinical use in horses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabidiolHorsesAnimalsBiological AvailabilityChromatography, LiquidTandem Mass SpectrometryAdministration, Oral

Stichwörter der Autor:innen

bioavailabilitycannabidiolhorsemicellaroilpharmacokinetics

Substanzen

Cannabidiol

Autor:innen und Institutionen

  • Veterinary Clinical Hospital, University of Cordoba, Córdoba, Spain.
  • Department of Animal Medicine and Surgery, Veterinary Faculty, University of Cordoba, Córdoba, Spain.
  • Department of Nursing, Pharmacology and Physiotherapy, Veterinary Faculty, University of Córdoba, Córdoba, Spain.
  • Phytoplant Research S.L.U., Córdoba, Spain.
  • Equine Sport Medicine Center CEMEDE, Department of Animal Medicine and Surgery, Veterinary Faculty, University of Córdoba, Córdoba, Spain.

ORCID-Profile: Juan Manuel Serrano-Rodríguez, Elisa Díez de Castro, Ana Muñoz, Verónica Sánchez de Medina

Förderung

  • Phytoplant Research S.L.U.
  • Institut Hospital del Mar d'Investigacions Mèdiques
  • Hospital Del Mar Medical Research Institute

Zitieren

APA

Sánchez de Medina, A., Serrano-Rodríguez, J. M., Díez de Castro, E., García-Valverde, M. T., Saitua, A., Becero, M., Muñoz, A., Ferreiro-Vera, C., & Sánchez de Medina, V. (2023). Pharmacokinetics and oral bioavailability of cannabidiol in horses after intravenous and oral administration with oil and micellar formulations. Equine Veterinary Journal. https://doi.org/10.1111/evj.13923

Vancouver

Sánchez de Medina A, Serrano-Rodríguez JM, Díez de Castro E, García-Valverde MT, Saitua A, Becero M, et al. Pharmacokinetics and oral bioavailability of cannabidiol in horses after intravenous and oral administration with oil and micellar formulations. Equine Veterinary Journal. 2023. doi:10.1111/evj.13923

BibTeX
@article{SnchezdeMedina2023,
  author = {Sánchez de Medina, Antonia and Serrano-Rodríguez, Juan Manuel and Díez de Castro, Elisa and García-Valverde, María Teresa and Saitua, Aritz and Becero, Mireia and Muñoz, Ana and Ferreiro-Vera, Carlos and Sánchez de Medina, Verónica},
  title = {Pharmacokinetics and oral bioavailability of cannabidiol in horses after intravenous and oral administration with oil and micellar formulations},
  journal = {Equine Veterinary Journal},
  year = {2023},
  doi = {10.1111/evj.13923}
}
Kostenlos starten →